ScandiDos AB logo

ScandiDos AB (SDOS)

Market Closed
10 Aug, 15:25
XSTO XSTO
kr
0. 92
+0.03
+2.809%
kr
47.32M Market Cap
- P/E Ratio
- Div Yield
119,542 Volume
0 Eps
kr 0.89
Previous Close
Add Transaction
Day Range
0.86 0.92
Year Range
0.9 1.5
Want to track SDOS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

SDOS closed today higher at kr0.92, an increase of 2.809% from yesterday's close, completing a monthly decrease of -8.0402% or -kr0.08. Over the past 12 months, SDOS stock lost -20.4348%.
SDOS is not paying dividends to its shareholders.
The last earnings report, released on Mar 10, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.0126%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

SDOS Chart

People also search for

OncoZenge AB
kr 5.75
-7.4074%
FRISQ Holding AB
kr 0.7
+6.383%
GPX Medical AB
kr 2.13
-0.9302%
Redsense Medical AB
kr 4
+0.2506%
2cureX AB
kr 1.65
+0.8537%

ScandiDos AB (SDOS) FAQ

What is the stock price today?

The current price is kr0.92.

On which exchange is it traded?

ScandiDos AB is listed on XSTO.

What is its stock symbol?

The ticker symbol is SDOS.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 47.32M.

Has ScandiDos AB ever had a stock split?

No, there has never been a stock split.

ScandiDos AB Profile

Health Care Technology Industry
Healthcare Sector
Mr. Anders Murman CEO
XSTO Exchange
SE0005768124 ISIN
SE Country
25 Employees
- Last Dividend
7 May 2019 Last Split
- IPO Date

Overview

ScandiDos AB (publ) is a leading company specializing in the development and provision of advanced measurement systems and software tailored for the quality assurance (QA) and validation of modern dynamic and modulated radiation therapy treatments in clinical settings globally. Founded in 2001 and with its headquarters located in Uppsala, Sweden, the company has established a strong presence in the radiation therapy sector. ScandiDos focuses on delivering innovative solutions that ensure the accurate and effective implementation of complex treatment modalities such as Volumetric Modulated Arc Therapy (VMAT), RapidArc, Intensity-Modulated Radiation Therapy (IMRT), and Tomotherapy, catering to the evolving needs of clinics and patients alike.

Products and Services

  • Delta4 Discover - This cutting-edge solution is designed to provide real-time, in-vivo dosimetry verification for advanced radiation therapy procedures. By ensuring the delivered dose matches the planned treatment dose directly during the patient treatment, Delta4 Discover enhances treatment accuracy and patient safety. It addresses the critical need for dynamic and modulated treatment verification, offering peace of mind for both practitioners and patients.
  • Delta4 Phantom+ - An innovative phantom system specifically developed for the pre-treatment QA of radiation therapy. Delta4 Phantom+ allows for the highly accurate and efficient validation of treatment plans before they are administered to patients. This system supports a wide range of advanced therapy procedures such as VMAT, RapidArc, IMRT, and Tomotherapy. By enabling comprehensive analysis and validation, the Delta4 Phantom+ plays a pivotal role in the optimization of treatment plans and the assurance of precise treatment delivery.

Contact Information

Address: Uppsala Science Park, Uppsala, Sweden, 751 83
Phone: 46 1 84 72 30 30